TargetRx Announces Management Transition
Craig Scott Assumes Chief Executive Officer Position

Horsham, PA - January 28, 2008 - TargetRx Inc. today announced that Craig H. Scott has been appointed to the role of president and chief executive officer, and he will join the board of directors, effective immediately. Scott assumes the role from Michael J. Luby, company founder who will remain a full-time employee of the company and a member of the board of directors.

"We are pleased to have established TargetRx as the only company to enhance pharmaceutical sales force and marketing effectiveness by helping clients to measure, manage and improve performance against the key drivers of physician prescribing behavior. I am confident Craig's proven leadership abilities will propel the company into its next phase of growth," said Luby. "I believe his wealth of experience in the pharmaceutical services industry, combined with his energy and vision, will be great assets to the future success of TargetRx."

Scott joins TargetRx with a broad range of pharmaceutical marketing, sales and general management experience on both the client and service sides, and in both Fortune 100 and entrepreneurial start-up organizations. Prior to joining TargetRx, he was president of the Catalina Health Resource division of Catalina Marketing Corporation from 2004 until the leveraged buyout of the company in November 2007. During his tenure, he dramatically increased revenues and profits and led the transformation of Catalina Health Resource into the leading provider of direct-to-patient communication services in pharmacies nationwide.

Scott joined Catalina after nine years with Nelson Communications, where he established several new healthcare marketing ventures, leading them from concept to implementation and commercial success. Prior to his work at Nelson Communications, Scott spent 13 years with Johnson & Johnson, where he held a variety of marketing and management positions. Most notably at J&J, Scott served as vice president of marketing as well as a management board member for Vistakon, the J&J affiliate that launched ACUVUE�, the first disposable and best-selling contact lens in the world.

"I am enthused by TargetRx's proprietary predictive modeling database," said Scott. "With a comprehensive understanding of physician attitudes about products, promotion, payors and patients, we can offer pharmaceutical companies robust information that will fundamentally improve the effectiveness of their sales and marketing efforts. At this critical time for the industry, TargetRx will continue to provide clients with superior tools that will enable them to increase market share and improve the bottom line."

Scott received his bachelor's degree in semiotics from Brown University and his master's degree in business administration from The Wharton School of Business at the University of Pennsylvania. He currently resides in Doylestown, Pennsylvania with his wife and their two children.

About TargetRx
TargetRx helps pharmaceutical companies create competitive advantage and shareholder value through unparalleled insights into the drivers of physician prescribing behavior. TargetRx products and services help pharmaceutical clients to deploy more effective and efficient sales and marketing programs. TargetRx employs a unique database approach to capturing physician attitudes and translating the findings into highly actionable insight for its clients. TargetRx has developed a highly predictive, large-scale normative database of physician attitudes that it uses in combination with its patented proprietary analytic methods to provide pharmaceutical companies with powerful "leading indicators" of performance. These insights provide companies with benchmarks for how they are currently performing, rich diagnostics that identify immediate ways to improve, and powerful forecasts that accurately predict future performance. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit www.targetrx.com or call 215-444-8900.

Media Contact:

Susan Lombardo
Lois Paul & Partners
781.782.5767
susan_lombardo@lpp.com